Building upon its efforts to provide greater access to vaccines and other health care services for populations in need, Walgreens (NYSE: WAG) (Nasdaq: WAG) is partnering with the United Nations Foundation this flu season, to help provide up to 3 million life-saving vaccines to children in developing countries through a donation to the Foundation’s Shot@Life campaign.
To view Multimedia News Release, go to http://www.multivu.com/players/English/62923-walgreens-flu-season2013
University Hospitals Case Medical Center was recognized today as a national model for quality care as the recipient of the 2012 American Hospital Association-McKesson Quest for Quality Prize. The prestigious award named UH Case Medical Center the top hospital in the nation for its leadership and innovation in quality improvement and safety.
UH Case Medical Center was selected by a multi-disciplinary committee of health care quality and patient safety experts. The American Hospital Association (AHA)-McKesson Quest for Quality Prize is presented annually and UH Case Medical Center is the first large, urban academic medical center to earn this coveted prize.
To view Multimedia News Release, go to https://www.multivu.com/mnr/57289-american-hospital-association-uh-case-medical-center-leader-in-quality
Approximately one-third of teens may be missing annual checkups according to data from the US Department of Health and Human Services and the US Census. Teens often encounter social, emotional, and physical issues that may include eating disorders and obesity, substance abuse, and sexually transmitted infections. While experts agree that teens should get annual medical checkups to be screened for health risks and discuss important health-related matters, perceptions exist that may contribute to millions of teens missing out on yearly visits. To better understand perceptions about teen health, the National Foundation for Infectious Diseases (NFID), in collaboration with, and with support from Pfizer Inc, conducted a national survey, fielded by Harris Interactive, of more than 2,000 parents of teens, teens, and healthcare professionals.
To view Multimedia News Release, go to http://www.multivu.com/players/English/60287-nfid-myteenhealth-survey/
The USPSTF today issued a draft recommendation giving its second highest approval rating for CT screening for lung cancer for those at high risk, a move that if approved in final form, will trigger Medicare and insurance coverage and bring about a dramatic drop in the leading cause of cancer deaths.
Today, LCA also launched its Risk Navigator tool – www.AtRiskForLungCancer.org. Additionally, it expanded the hours of its support line – (800) 298-2436 – operating 8 a.m. to 7 p.m. EST. LCA will also launch a national educational advertising campaign in September to encourage the public to know their risk for lung cancer.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62719-lung-cancer-alliance-uspstf-recommends-ct-screening-for-lung-cancer
Persistent deterioration of short-term memory, progressive confusion and disorientation and frequent agitation are characteristic of Alzheimer’s disease. We have been told that it is largely genetic but that there are some things that can be done to reduce the severity or how early the onset is. We can’t change our genetic makeup but we can change our behavior to help mitigate the effects of this type of dementia. These are all things we can accomplish with a little determination and planning. http://youtu.be/9eMrmVMuAa0
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
Many parents had their children vaccinated when they were younger, but some vaccines are also recommended for older children. Beyond focusing on school supplies, extracurricular activities, and fall schedules, the back-to-school time is a good opportunity for parents to talk with their health care professional about vaccines that may be recommended for their preteen or teen.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62743-merck-webmd-healthywomen-back-to-school-means-back-to-vaccines
Video gamers, roller coaster riders, surfers and music lovers across the country will be able to experience the fun and educational messages of the nation’s largest youth smoking prevention campaign. truth® begins its 14th annual nationwide summer tour on Saturday, June 15 in Seattle with its first stop on the Vans Warped Tour. truth’s crew of young adult “tour riders” will interact with teens across the country – educating them about the marketing tactics of the tobacco industry and the health effects, addictiveness and social consequences of tobacco use.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58845-truth-youth-smoking-prevention-summer-tour-to-travel-more-than-30-states
Is life making you stressed? Learn about the easy, do-anywhere 4-7-8 breathing technique that will help you get through your day. In her new book Life Is Your Best Medicine, Dr. Tieraona Low Dog weaves together the wisdom of traditional medicine and the knowledge of modern-day medicine into an elegant message of health and self-affirmation for women of every age. http://bit.ly/LifeMedicine Nonfiction, self help
According to the results of a recent study conducted by researchers at the USDA-Agricultural Research Service Western Human Nutrition Research Center, the Northwest Cherry Growers are pleased to announce that consuming about 45 (280 g) sweet Bing cherries significantly decreased circulating concentrations of specific inflammatory biomarkers in the blood. According to Dr. Kent Erickson, Professor at UC Davis School of Medicine and a collaborator in the study, “Many studies by other investigators have demonstrated that some of those inflammation markers are associated with increased risk for some chronic diseases such as cardiovascular disease, diabetes, and cancer.” The findings of the study have been published in the March 2013 issue of The Journal of Nutrition.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61851-northwest-cherries-usda-study-health-benefits
Eight out of 10 people will be affected by back pain at some point during their lives, making it the No. 1 cause of disability worldwide and resulting in as much as $200 billion in lost wages and productivity. Many sufferers struggle for years to find relief, but treatment options often only provide short-term relief or, in the case of pain medication, carry serious side effects, including drowsiness, liver damage and potential for addiction. Now, thanks to Hocoma, a leader in the development of robotic and sensor-based medical devices for functional movement therapy, consumers have a new way to improve and sustain low back health in the comfort of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7370551-hocoma-innovative-medical-device-therapeutic-gaming-technology-valedo-low-back-health/
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
